So-Soo-Yoo®

Archexin offers potential to target and deal with multiple life-threatening cancers.

Archexin offers potential to target and deal with multiple life-threatening cancers, finds new study Rexahn Pharmaceuticals, Inc tadalafil ohne rezept tadalafilschweiz.com . AKT1 may promote cell survival and is normally therefore implicated in tumor growth in an array of cancers. Related StoriesViralytics enters into medical trial collaboration contract with MSDNew findings reveal association between colorectal tumor and melanoma drug treatmentMeat-rich diet may boost kidney cancer riskThe research to be released in the Journal of Cellular Biochemistry on November 1, 2009 , also discovered that the mixed treatment of AKT1 AO with cytotoxic medications showed even greater anti-tumor activity in individual renal carcinoma cell series.